Final FDA rule on device, drug and biologic combos is available

01/23/2013 | MassDevice.com (Boston)

A final rule released this week by the FDA outlines current good manufacturing practice standards for products that combine drugs, medical devices and biologics. The rule aims to clarify the CGMP criteria for new and existing combination products that are sold together or are "single-entity" combinations.

View Full Article in:

MassDevice.com (Boston)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Catheter Engineer
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
SAFETY, HEALTH, and ENVIRONMENTAL (SHE) REGIONAL SPECIALIST
Matheson Tri-Gas, Inc.
Newark, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
MANAGER MEDICAL GAS COMPLIANCE AND SAFETY
Matheson Tri-Gas, Inc.
Houston, TX
Quality Engineer
BiOM
Bedford, MA